ENTPD1 and colitis: Importantly, and of high translational and clinical relevance, treatment with oligonucleotides inhibiting the CD39-AS RNA ameliorates the course of TNBS colitis in NOD/scid/gamma mice, adoptively transferred with antisense+ human CD4 cells.